Invesaro

Stocks Health care GMED

NYSE · Health care

Globus Medical Inc (GMED)

Globus Medical Inc brought in $3.1B of revenue over the twelve months to June 30, 2026, up 19.7% from a year earlier. Net income was $535.4M, a net margin of 17.0%. Operating cash flow minus capital spending left $588.8M of free cash flow in fiscal 2025. At June 30, 2026 it held $507.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.

Price
$74.52
+0.34% on the day · September 25, 2026
52-week range $55.33 to $101.40
Market cap
$10B
Revenue (last 12 months)
$3.1B
+19.7% year on year
Net margin
17.0%
P/E
19.0
on FY2025 diluted EPS

What Globus Medical Inc does

Globus Medical Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker GMED.

Revenue and profit by year

Revenue
FY18: $713M $713M FY18FY19: $785.4M $785.4M FY19FY20: $789M $789M FY20FY21: $958.1M $958.1M FY21FY22: $1B $1B FY22FY23: $1.6B $1.6B FY23FY24: $2.5B $2.5B FY24FY25: $2.9B $2.9B FY25
Net income
FY18: $156.5M $156.5M FY18FY19: $155.2M $155.2M FY19FY20: $102.3M $102.3M FY20FY21: $149.2M $149.2M FY21FY22: $190.2M $190.2M FY22FY23: $122.9M $122.9M FY23FY24: $103M $103M FY24FY25: $537.9M $537.9M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$2.9B$479.8M$537.9M$3.92$588.8M
2024$2.5B$166M$103M$0.75$405.2M
2023$1.6B$133.1M$122.9M$1.07$165.2M
2022$1B$228M$190.2M$1.85$104.4M
2021$958.1M$172M$149.2M$1.44$219.4M
2020$789M$111.4M$102.3M$1.01$135.1M

Latest SEC filings

What Globus Medical Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 6, 2026
    Quarterly report 10-Q · period to June 30, 2026
  2. August 6, 2026
  3. June 4, 2026
  4. May 27, 2026
  5. May 7, 2026
    Quarterly report 10-Q · period to March 31, 2026
  6. May 7, 2026
  7. April 30, 2026
  8. April 24, 2026
  9. April 24, 2026
  10. March 26, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 16, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about GMED

What does Globus Medical Inc do?

Globus Medical Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker GMED.

Is Globus Medical Inc profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $535.4M on revenue of $3.1B, a net margin of 17.0%.

How much revenue does Globus Medical Inc make?

Over the twelve months to June 30, 2026 Globus Medical Inc reported revenue of $3.1B. That is 19.7% more than a year earlier.

When did Globus Medical Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 16, 2026.

Similar companies

Follow GMED

Get an email when Globus Medical Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow GMED: get an email when it files

Where the numbers come from

Financial figures are the values Globus Medical Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.